XML 62 R49.htm IDEA: XBRL DOCUMENT v3.22.4
Note 21 - Parent Corporation Only Financial Statements (Tables)
12 Months Ended
Dec. 31, 2022
Notes Tables  
Condensed Balance Sheet [Table Text Block]
  

As of December 31,

 
  

2022

  

2021

 
  

(dollars in thousands)

 

ASSETS

        

Cash and cash equivalents

 $117,162  $133,648 

Investment in subsidiaries

  1,179,342   1,111,520 

Investment securities

  32,405   32,405 

Equity securities

  4,218   725 

Other assets

  699   699 

Total assets

 $1,333,826  $1,278,997 

LIABILITIES AND STOCKHOLDERS’ EQUITY

        

Other liabilities

  1,820   1,834 

Subordinated debentures, net

  153,255   152,951 

Stockholders’ equity

  1,178,751   1,124,212 

Total liabilities and stockholders’ equity

 $1,333,826  $1,278,997 
Condensed Income Statement [Table Text Block]
  

For Years Ended December 31,

 
  

2022

  

2021

  

2020

 
  

(dollars in thousands)

 

Income:

            

Dividend income from subsidiaries

 $36,475  $24,071  $15,200 

Other income

  1,638   1,627   1,683 

Total Income

  38,113   25,698   16,883 

Expenses

  (8,928)  (8,741)  (9,263)

Income before equity in undistributed earnings of subsidiaries

  29,185   16,957   7,620 

Equity in undistributed earnings of subsidiaries

  96,026   113,396   63,669 

Net Income

  125,211   130,353   71,289 

Preferred dividends

  6,037   1,717   - 

Net income available to common stockholders

 $119,174  $128,636  $71,289 
Condensed Cash Flow Statement [Table Text Block]
  

For Years Ended December 31

 
  

2022

  

2021

  

2020

 
  

(dollars in thousands)

 
             

Cash flows from operating activities:

            

Net income

 $125,211  $130,353  $71,289 

Adjustments to reconcile net income to net cash provided by operating activities:

            

Equity in undistributed earnings of subsidiary

  (96,026)  (113,396)  (63,669)

Loss on equity securities, net

  45   55   - 

Amortization of subordinated debt issuance costs

  304   303   323 

Decrease (increase) in other assets

  -   50,590   (50,001)

Decrease in other liabilities

  (14)  (287)  (391)

Net cash provided by (used in) operating activities

  29,520   67,618   (42,449)
             

Cash flows from investing activities:

            

Sale of equity securities

  (3,538)  (780)  - 

Repayment of short-term borrowing

  -   -   (3,000)

Net cash used in investing activities

  (3,538)  (780)  (3,000)
             

Cash flows from financing activities:

            

Proceeds from (repayment of) proceeds from subordinated debt

  -   (50,000)  73,440 

Cash dividends paid on preferred stock

  (6,037)  (1,717)  - 

Cash dividends paid on common stock

  (23,428)  (17,493)  (14,317)

Purchase of treasury stock

  (13,127)  (9,401)  (911)

Proceeds from preferred stock offering

  -   110,927   - 

Proceeds from exercise of stock options

  124   106   233 

Net cash (used in) provided by financing activities

  (42,468)  32,422   58,445 
             

Decrease (increase) in cash and cash equivalents

  (16,486)  99,260   12,996 

Cash and cash equivalents as of January 1,

  133,648   34,388   21,392 

Cash and cash equivalents as of December 31,

 $117,162  $133,648  $34,388